Korean Circulation Journal

  • 제52권8호
  • /
  • Pages.604-605
  • /
  • 2022
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

A 'Gender Paradox' of Female as a Stroke Risk in Atrial Fibrillation: Do Women Live Longer Than Men?

  • Joo Hee Jeong (Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine and Korea University Medical Center) ;
  • Jong-Il Choi (Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine and Korea University Medical Center)
  • 투고 : 2022.06.20
  • 심사 : 2022.06.30
  • 발행 : 2022.08.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72. https://doi.org/10.1378/chest.09-1584
  2. Cho SM, Lee H, Kim HC. Sex- and age-specific trends in cardiovascular health in Korea, 2007-2018. Korean Circ J 2021;51:922-35. https://doi.org/10.4070/kcj.2021.0211
  3. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373-498. https://doi.org/10.1093/eurheartj/ehaa612
  4. Apostolakis S, Sullivan RM, Olshansky B, Lip GY. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score. Chest 2013;144:1555-63. https://doi.org/10.1378/chest.13-0054
  5. Yong CM, Tremmel JA, Lansberg MG, Fan J, Askari M, Turakhia MP. Sex differences in oral anticoagulation and outcomes of stroke and intracranial bleeding in newly diagnosed atrial fibrillation. J Am Heart Assoc 2020;9:e015689.
  6. Sullivan RM, Zhang J, Zamba G, Lip GY, Olshansky B. Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). Am J Cardiol 2012;110:1799-802. https://doi.org/10.1016/j.amjcard.2012.08.014
  7. Wang KL, Lip GY, Lin SJ, Chiang CE. Non-vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis. Stroke 2015;46:2555-61. https://doi.org/10.1161/STROKEAHA.115.009947
  8. Kim M, Kim J, Kim JB, et al. Association of gender with clinical outcomes in a contemporary cohort of patients with atrial fibrillation receiving oral anticoagulants. Korean Circ J 2022;52:593-603. https://doi.org/10.4070/kcj.2021.0399
  9. Lee KN, Choi JI, Boo KY, et al. Effectiveness and safety of off-label dosing of non-vitamin K antagonist anticoagulant for atrial fibrillation in Asian patients. Sci Rep 2020;10:1801.
  10. Kim YG, Han KD, Kim DY, et al. Different influence of blood pressure on new-onset atrial fibrillation in pre- and postmenopausal women: a nationwide population-based study. Hypertension 2021;77:1500-9. https://doi.org/10.1161/HYPERTENSIONAHA.120.16513